Medtronic Debt-to-Equity Ratio Growth & History (MDT)
Medtronic's debt-to-equity ratio was 0.55 for fiscal 2026.
View full Medtronic company overviewMedtronic annual debt-to-equity ratio history
| Fiscal year | Period ended | Debt-to-equity ratio | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-04-24 | 0.55 | −0.00 | −0.70% |
| 2025 | 2025-04-25 | 0.56 | 0.04 | +7.46% |
| 2024 | 2024-04-26 | 0.52 | 0.03 | +5.10% |
| 2023 | 2023-04-28 | 0.49 | 0.09 | +22.02% |
| 2022 | 2022-04-29 | 0.40 | −0.13 | −24.11% |
| 2021 | 2021-04-30 | 0.53 | 0.02 | +4.30% |
| 2020 | 2020-04-24 | 0.51 | 0.00 | +0.69% |
| 2019 | 2019-04-26 | 0.51 | −0.00 | −0.10% |
| 2018 | 2018-04-27 | 0.51 | −0.16 | −23.67% |
| 2017 | 2017-04-28 | 0.67 | 0.07 | +11.93% |
| 2016 | 2016-04-29 | 0.59 | −0.07 | −11.16% |
| 2015 | 2015-04-24 | 0.67 | 0.14 | +26.08% |
| 2014 | 2014-04-25 | 0.53 | — | — |
Medtronic quarterly debt-to-equity ratio
| Fiscal quarter | Period ended | Debt-to-equity ratio | Change | YoY change |
|---|---|---|---|---|
| Q1 2027 | 2026-07-31 | 0.51 | −0.04 | −6.70% |
| Q4 2026 | 2026-04-24 | 0.55 | −0.00 | −0.70% |
| Q3 2026 | 2026-01-31 | 0.57 | 0.09 | +18.00% |
| Q3 2026 | 2026-01-23 | 0.57 | 0.08 | +17.19% |
| Q2 2026 | 2025-10-24 | 0.57 | 0.06 | +12.12% |
| Q1 2026 | 2025-07-25 | 0.55 | −0.00 | −0.39% |
| Q4 2025 | 2025-04-25 | 0.56 | 0.04 | +7.46% |
| Q3 2025 | 2025-01-24 | 0.49 | 0.02 | +4.14% |
| Q2 2025 | 2024-10-25 | 0.51 | 0.05 | +9.99% |
| Q1 2025 | 2024-07-26 | 0.55 | 0.07 | +14.81% |
| Q4 2024 | 2024-04-26 | 0.52 | 0.03 | +5.10% |
| Q3 2024 | 2024-01-26 | 0.47 | 0.03 | +8.01% |
| Q2 2024 | 2023-10-27 | 0.46 | 0.06 | +15.33% |
| Q1 2024 | 2023-07-28 | 0.48 | 0.15 | +44.03% |
| Q4 2023 | 2023-04-28 | 0.49 | 0.09 | +22.02% |
| Q3 2023 | 2023-01-27 | 0.43 | −0.03 | −6.61% |
| Q2 2023 | 2022-10-28 | 0.40 | −0.09 | −18.78% |
| Q1 2023 | 2022-07-29 | 0.33 | −0.17 | −34.17% |
| Q4 2022 | 2022-04-29 | 0.40 | −0.13 | −24.11% |
| Q3 2022 | 2022-01-28 | 0.46 | −0.06 | −11.46% |
| Q2 2022 | 2021-10-29 | 0.49 | −0.03 | −4.85% |
| Q1 2022 | 2021-07-30 | 0.50 | 0.05 | +10.89% |
| Q4 2021 | 2021-04-30 | 0.53 | 0.02 | +4.30% |
| Q3 2021 | 2021-01-29 | 0.52 | 0.03 | +5.04% |
| Q2 2021 | 2020-10-30 | 0.52 | 0.01 | +1.63% |
| Q1 2021 | 2020-07-31 | 0.45 | −0.06 | −11.19% |
| Q4 2020 | 2020-04-24 | 0.51 | 0.00 | +0.69% |
| Q3 2020 | 2020-01-24 | 0.50 | 0.02 | +4.62% |
| Q2 2020 | 2019-10-25 | 0.51 | 0.03 | +6.74% |
| Q1 2020 | 2019-07-26 | 0.51 | 0.04 | +8.59% |
| Q4 2019 | 2019-04-26 | 0.51 | −0.00 | −0.10% |
| Q3 2019 | 2019-01-25 | 0.48 | −0.04 | −7.92% |
| Q2 2019 | 2018-10-26 | 0.48 | −0.03 | −5.32% |
| Q1 2019 | 2018-07-27 | 0.47 | −0.04 | −7.95% |
| Q4 2018 | 2018-04-27 | 0.51 | −0.16 | −23.67% |
| Q3 2018 | 2018-01-26 | 0.52 | −0.01 | −1.71% |
| Q2 2018 | 2017-10-27 | 0.50 | −0.07 | −12.81% |
| Q1 2018 | 2017-07-28 | 0.51 | −0.08 | −13.59% |
| Q4 2017 | 2017-04-28 | 0.67 | 0.07 | +11.93% |
| Q3 2017 | 2017-01-27 | 0.52 | −0.14 | −20.81% |
| Q2 2017 | 2016-10-28 | 0.58 | −0.07 | −10.32% |
| Q1 2017 | 2016-07-29 | 0.59 | −0.05 | −7.14% |
| Q4 2016 | 2016-04-29 | 0.59 | −0.07 | −11.16% |
| Q3 2016 | 2016-01-29 | 0.66 | — | — |
| Q2 2016 | 2015-10-30 | 0.64 | — | — |
| Q1 2016 | 2015-07-31 | 0.64 | — | — |
| Q4 2015 | 2015-04-24 | 0.67 | — | — |
Medtronic debt-to-equity ratio trends
Over the last five fiscal years, Medtronic's debt-to-equity ratio increased from 0.53 to 0.55, a change of 0.02. The latest reported quarter, Q1 2027, shows 0.51.
What the debt-to-equity ratio means
The debt-to-equity ratio compares interest-bearing debt with shareholders’ equity. It helps show how much debt financing a company uses relative to its accounting equity, but useful comparison levels vary by industry.
How debt-to-equity is calculated
TickerStat calculates debt-to-equity as total interest-bearing debt divided by SEC-reported shareholders’ equity for the same balance-sheet date. Total liabilities are not treated as debt, and periods with non-positive equity are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Medtronic source filings ↗Community posts
Medtronic begins European clinical use of its Stealth AXiS surgical system
Medtronic ($MDT) announced the first European procedures using its Stealth AXiS surgical system, with more than 23 procedures performed across seven sites in Germany, the UK, Italy and Spain. The initial experience includes spinal surgery. ...